FindTrial
Sign In

Effect of Amrajambupraval Kashaya in the Management of Nausea and Vomiting During Pregnancy

A Clinical Study To Evaluate The Effect Of Amrajambupravala Kashaya In Management Of Garbhini Chhardi - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109372
Enrollment
40
Registered
2026-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O210- Mild hyperemesis gravidarum

Interventions

None listed

Sponsors

Seth RV Ayurved Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with age from 19-40 years. Patients having confirmed diagnosis of pregnancy. Pregnant women must complain of vomiting 1-5 times day with nausea (morning sickness) in the 1st and 2nd trimesters. patient from all socioeconomic class. Patient willing for participate in research with informed consent

Exclusion criteria

Exclusion criteria: Patients with hyper emesis gravidarum. Patients with vesicular mole and ectopic pregnancy. Vomiting caused due to systemic disorder like peptic ulcer, renal calculi and appendicitis. Patients having vomiting in 3rd trimesters.

Design outcomes

Primary

MeasureTime frame
Reduction in frequency and severity of vomiting (Chhardi) and associated nausea (Hrullasa) after 7 days of treatment with Amrajambupraval Kashaya, assessed using grading scale on Day 1, Day 3, Day 7, and Day 15 follow-up.Timepoint: 7 Days—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Sujata Shrikant Jagtap

APMs Ayurved Mahavidyalaya Sion

supriyasawant6810@gmail.com9307224599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026